Sign in with Google
|
USD 363.25
Price
-23.02
(-5.96%)
Day Change
|
|
|---|
UTHR, the overall quality is good (Quality = 77) and the timing to buy is ...(Sign In to See)...
Loading chart...
- Signal
- OUTPERFORM
- Signal Description
- Company financial health is Good
- Reason
-
Acceleration of ROE growth rate is below our criteria.
Acceleration of ROA growth rate is below our criteria.
Acceleration of net profit margin growth rate is below our criteria
In details, quality factors are not quite good , financial health is not quite good , and ability to make profit is good , ...
| Quality Factors |
|
52% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| Social Score | 10 |
| Magic Formula Rank by ROA |
420
|
| Magic Formula Rank by ROE |
420
|
| Magic Formula Rank by ROIC |
394
|
| Price | 363.25 |
| PBV / Sector |
2.66 / 1.39
|
| Earning Per Share | 21.40 |
| PE / Sector |
16.97 / 17.53
|
| PEG or PE/Growth / Sector |
1.67 / 5.75
|
| Average 1M Daily Value |
146.83 M
GREAT
|
| Average 1W Daily Value |
153.76 M
GREAT
|
| Timing Factors |
|
42% |
| Financial Health |
|
58% |
| Key Statistics |
|
77% |
| Return to Investors |
|
41% |
| Registration Details |
| Analyze Date | 2024-11-16 19:31:54 |
| Symbol | UTHR |
| Name | UNITED THERAPEUTICS CORPORATION |
| Sector | Healthcare >> Biotechnology |
| Market | NASDAQ |
| Listed Shares | 44.64 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 17,244.82 / 3,831.30 |
| News, Concensus, ... |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
EXEL 
RPRX 
